ONdrugDelivery Magazine

15/11/2023

We’re delighted to present our latest article on the benefits of automation for MDI, nasal spray, and nasal aerosol testing in the latest issue of ONdrugDelivery Magazine. Spotlighting the newly launched Vertus® III+ and DecaVertus® III, our article offers readers an in-depth review of the ever-changing OINDP testing landscape and how these innovative systems are designed to ensure reliable results, every time.

Read it here: https://bit.ly/3QAMF0A

01/08/2023

07/07/2023

"The enFuse could alleviate the challenges pharma companies face when considering large subcutaneous delivery options by accommodating a range of drug viscosities and volumes while utilizing the original container closure. The original container closure and the high-volume capacity could reduce development time for pharma when converting drugs from IV to SC or from SC to SC with an OBDS.” - Mehul Desai, PharmD, MBA, VP of Medical Affairs at Enable Injections

Read more about how the enFuse system could benefit pharma companies in our recent ONdrugDelivery Magazine article: https://lnkd.in/gV6qEcpS

07/07/2023

Join Giorgio Sardo, Senior Design Systems Engineer, in his latest with ONdrugDelivery Magazine, as he dives deep into the world of of plastics in and , and their impact on driving sustainable change.

See the results of tests comparing the performance of sustainable bio-based plastic resins with their fossil-based counterparts in his recent article. Learn more: https://fal.cn/3yvIT

07/07/2023

Chelsea Williams, Nils Weber and Gene Rhode Fuensalida Pantig discuss the potential of collaborative innovation in connected drug delivery when it comes to creating high-impact, low-touch adherence solutions.

07/07/2023

We've just published our 150th Issue! Out now, July's edition of ONdrugDelivery Magazine focuses on "Industrialising Drug Delivery" from cover-to-cover. Read it all here👉 https://bit.ly/3JM8kAj .

All about scaling-up drug delivery systems from concept/R&D through to production at large-scale volumes for market, this edition includes Expert Views from Phil Sampey of Haughton Design, who discusses design-for-manufacture (DFM) and design-for-assembly (DFA) methodologies; and Matt Burton of IMed Consultancy Ltd, with a guide to entering the UK market, which has become a particularly appealing option amidst delays with the EU's MDR. We also have an exclusive interview with Julien Martins and Dave Philbrick from high-precision metal components manufacturer Paragon Medical, who talked with Guy Furness about the services Paragon provides the drug delivery industry, its wider business operations, the company’s expanded facilities in the US and Europe, and its new Advanced Surgical Innovation Center.

Mads Hansen presents an overview of Stevanato Group’s Standard Autoinjector Assembly Machine platform. From precision mould-maker Igs GeboJagema, Hans Arts, Jan-Willem Den Hollander and Ron Cisliek highlight the value of bringing an industrialisation partner on board early in product development. Jennifer Riter and Victoria Morgan of West Pharmaceutical Services, discuss the importance of choosing the right containment system at the start for successful industrialisation of an injectable drug product. Particle Works' Ben Knappett shows how rapid and cost-effective high-throughput lipid nanoparticle technology formulation can be achieved via a combination of microfluidics with automation. And from Becton, Dickinson and Company, Yacine Haddadi and Hervé Soukiassian show how an RFID-based track & trace model can achieve true unit-level traceability for manufacturers' fill-finish operations.

Enjoy reading this 150th edition of ONdrugDelivery Magazine!

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

06/06/2023

The latest issue, focusing wholly on "ORAL DRUG DELIVERY" is out! Ready for you online 👉 https://bit.ly/3NfL8fV.

Inside this issue, which is oral drug delivery from cover-to-cover: an excellent article from Aruna Railkar, Ph.D, PMP of Quotient Sciences, outlining three case studies – one involving solubility enhancement, one modified release, and a paediatric dosage form – to illustrate the formulation challenges in complex drug programmes. Also on paediatric dosage forms, Roquette's Keat Theng Chow explores the latest developments in oral thin films and argues that this delivery modality has substantial untapped potential.

Regular contributor, powder characterisation specialist Granutools, explains how its instruments go beyond the standards, enabling keener insights and more repeatable analyses.

Evonik showcases EUDRACAP, its non-animal-derived platform of functional, ready-to-fill capsules for fast-track development of sensitive drugs. The HPMC capsules are functionalised with a coating based on the company's EUDRAGIT polymers.

Staying with capsules, Susana Ecenarro Probst, VP R&D at Qualicaps, introduces the company's TiO2-free hard capsule platform and discusses the challenges involved in replacing TiO2.

We have Expert Views in this issue from: Lonza Group's head of multliparticulates Jonathan Cape, who provide his insights into optimising release profiles by maximising the coating integrity of MR microspheres; ACG World's VP R&D Dr.Jnanadeva Bhat and Manali Dalvi, who describe how patients are benefitting from advances in capsule technology including solid-in-solid and liquid-in-solid applications; and Richard Ball of I Holland Ltd. takes us through advanced tablet design techniques and how these increase production success.

Also supporting this issue, highlighting a game-changing solubilisation product with applications in enabling and enhancing oral formulations, is Captisol (a Ligand technology).

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

22/05/2023

"DELIVERING INJECTABLES: DEVICES & FORMULATIONS" - It's out! ONdrugDelivery Magazine, Issue No. 147 is 100% focused on parenteral drug delivery. The full content can be found here 👉https://bit.ly/42ZwfUr

Inside Issue No. 147:

Aptar Pharma and Datwyler's articles both focus on Container Closure Systems (CCS), with Aptar's piece focusing specifically on cold-storage considerations. Team Consulting and Key Tech each contribute excellent Expert Views tackling different aspects of emergency use injectors.

Deepu Asok of Pfizer, with his first appearance in ONdrugDelivery provides his valuable Expert View on test method validation for combination products, focusing on injection devices.

From ten23 health, the issue features a nice article on the importance of an integrated offering across drug product development and manufacturing.

Appearing on our pages for the first time, we're pleased to welcome IMed Consultancy Ltd, sharing valuable expertise on how to maintain patient safety amid delays with the EU MDR.

Ypsomed's article, in the context of wearable injectors versus autoinjectors, discusses how patient and treatment factors influence SC dosing preferences. Nemera introduces its pen injector platform, PenVario, in the context of its end-to-end service offering. Mitsubishi Gas Chemical provides experimental data on its OXYCAPT advanced primary container material as applied to gene and cell therapy products. And Owen Mumford focuses on connectivity and human factors testing, with a feature about UniSafe autoinjector, a connected companion device for the UniSafe 1 mL safety device.

It's another superb issue. Read it all here 👉https://bit.ly/42ZwfUr

We're very grateful for additional support for this issue from Celanese Corporation, Credence MedSystems, DCA Design International Ltd, Enable Injections, SHL Medical, and West Pharmaceutical Services, Inc. - all key players offering products and solutions in and around parenteral drug delivery.

Enjoy it!

Remember - you can find ALL of our injectable drug delivery topic-tagged content in one place by simply visiting our home page and clicking the INJECTION link on the top menu.

(Next up, out within the next three weeks, we switch routes of administration, with the publication of our annual issue focusing wholly on "Oral Drug Delivery"!)

03/04/2023

The March/April issue is out! - "Skin Drug Delivery: Dermal, Transdermal & Microneedles" - ONdrugDelivery Magazine Issue 144. Ready to read here 👉https://bit.ly/3K96ZCG

Inside this issue: an excellent Expert View from Springboard giving an overview of the microneedles landscape and describing how numerous technologies have been inspired by nature; an Early Insight about a new needle-free injection device from medical device start-up NovaXS Biotech; feature articles from uPATCH, about its novel microneedle technology and applicator and URSATEC about preservative free dermal dispensing; and an Interview with Aptar Pharma VP Dr Stefan Hellbardt, who discusses the increasing demand for airless systems in the dermal drug delivery market.

Valued additional support for this issue, highlighting their role as key players in the skin/dermal drug delivery space are: Celanese Corporation and DCA Design International Ltd.

Enjoy!

13/03/2023

March's issue is out! - "Ophthalmic Drug Delivery" - ONdrugDelivery Issue #143. Ready to read here 👉https://bit.ly/3lagJo2

This edition includes valuable insights from leaders in the ophthalmic drug delivery space, including articles about delivery to the front of the eye and the back of the eye, topical/drops, IVT injection, implants and other classes of ocular delivery system.

We're particularly pleased to welcome three companies to our pages for the first time: EYE-GO A/S (their novel MistGo device is shown on the issue's front cover), Ora, Inc, and TTP. And regular expert contributors to ONdrugDelivery appearing in this issue are: Aero Pump GmbH, Congruence Medical Solutions, Celanese Corporation, Nemera, Springboard Pro, ten23 health, Terumo Corporation (Pharmaceutical Solutions Division) and Wuxi AppTec.

Valued additional support for this issue, highlighting their role as key players in the ocular drug delivery space are: Aptar Pharma, Credence MedSystems, and Nipro PharmaPackaging.

So, you know which companies are inside this the issue. Find out what insights and information these leading players in the ocular delivery sector have to share, here 👉https://bit.ly/3lagJo2

Enjoy!

10/02/2023

In ONdrug Delivery magazine's October issue on Pre-filled Syringes and Injection Devices, SHL Medical's Gary Calderwood, Raluca Ganea, and Gene Rhode Fuensalida Pantig talk about the evolving trends

30/01/2023

Just published and ready for you now! - "Prefilled Syringes & Injection Devices" - ONdrugDelivery Feb 2023, Issue #142. Access all the content here 👉 https://bit.ly/40csnhE

The first of the year and the first of our three regular annual issues focusing from cover-to-cover on the topic of injectable drug delivery, this edition includes valuable insights from leaders in the injectable drug delivery device space, including: Phillips Medisize, Aptar Pharma, ten23 health, Owen Mumford, SMC Ltd / Cambridge Pharma / Oval Medical Technologies, Enable Injections, Subcuject, Eitan Medical, Kymanox, West Pharmaceutical Services, Gerresheimer, Mitsubishi Gas Chemical, Stevanato Group, Glycome BioPharma, Congruence Medical Solutions, SHL Medical, Windgap Medical, Inc., EVEON, ZwickRoell and SCHERDELGruppe.

Valued additional support for this issue, highlighting their position as key players in the parenteral drug delivery space are: Becton, Dickinson and Company, Celanese Corporation, Credence MedSystems, DCA Design International, Haselmeier A medmix Brand, Jabil Healthcare, Nipro PharmaPackaging, and Ypsomed.

Read it here 👉 https://bit.ly/40csnhE

Enjoy it!

VISIT US AT PHARMAPACK

ONdrugDelivery will be at Pharmapack Europe, Stand S17 (left-hand side of the hall, near the Learning Lab). Please do come and visit us.

You can pick up a free printed copy of this February issue and other recent ONdrugDelivery issues from our stand.

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

14/12/2022

Just published and ready for you now! - "Connecting Drug Delivery" - the Dec 2022 issue of ONdrugDelivery (Issue #141) Access the full content here 👉 https://bit.ly/3PtNLtK

The second of our two annual issues focusing from cover-to-cover on the topic of Connectivity, this edition includes valuable insights from leaders in the drug delivery device connectivity space, including: Aptar Pharma and Noble, Debiotech, HCmed Innovations, Jabil Healthcare, Nemera, Owen Mumford, Sensirion, Vivera Pharmaceuticals and Ypsomed.

Valued additional support for this issue, highlighting their position as key players in the inhaled drug delivery space are: Celanese Corporation, Credence MedSystems, and DCA Design International Ltd.

Read the articles here 👉 https://bit.ly/3PtNLtK

Enjoy it!

As this is the last ONdrugDelivery of 2022, we wanted to take this opportunity to thank our expert authors, sponsors, advertisers and, most importantly, our many thousands of readers around the world, for your strong and ever-growing support throughout this year.

From ONdrugDelivery's publishing, editorial and creative team, all good wishes for the New Year ahead!

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

24/11/2022

Just published and ready for you now! - "Pulmonary & Nasal Delivery" - the Nov 2023 issue of ONdrugDelivery (Issue #140). Access the full content here 👉 https://bit.ly/3i7PHM3

100% topic focused on delivery, this is the biggest, best supported issue of ONdrugDelivery ever published on this topic. But we're particularly proud of the *quality* of content of this edition, which benefits from contributions from some of the sector's big hitters.

Among them: Iconovo AB Founder Orest Lastow, who runs through a good number of the critical factors at play in today's inhalation industry in his concise, insightful and intelligently written must-read article "Why are inhalation so difficult to develop"; John Pritchard and Elijah Nazarzadeh of Nebu~Flow, who (despite the modest title of their article) are describing nothing short of an entirely novel class of technology with remarkable potential; and serial inventor Klaus-Dieter Beller who, in addition to introducing his latest innovation, a novel ultra-simple, ultra-low-cost , begins his article with a thought-provoking commentary highlighting not only the incredible potential of the / routes but also the degree to which it still remains largely untapped.

More inhalation feature, including from Berry Global Healthcare, EVEON and HCmed Innovations.

Writing on inhalation as an alternative to , Philippe Rogueda founder of Merxin focuses on the delivery of via soft-mist inhalers, and regular star Expert View contributors . make the case for inhaled and nasal .

Nasal delivery features strongly, with Nanopharm, an Aptar Pharma Company / Aptar Pharma, Catalent Pharma Solutions, and Malvern Panalytical all contributing on this topic.

Analysis - e.g. (including properties), , and - is a particularly important field within . Solvias, Proveris Scientific Corporation, Granutools, Research Center Pharmaceutical Engineering (RCPE) and Medical Engineering Technologies all share their expertise here.

On , experts from precision mold maker IGS GeboJagema, specialty springs and stampings designer and manufacturer SCHERDEL Medtec North America, and advanced polymers leader Celanese Corporation share insights focusing specifically on inhalation devices.

Valued additional support for this issue, highlighting their position as key players in the inhaled drug delivery space are: DCA Design International, Gerresheimer, Nemera, Phillips-Medisize, Qualicaps & Recipharm.

Read it all here 👉 https://bit.ly/3i7PHM3

Enjoy!

17/11/2022

For some patients, the enFuse could potentially offer more flexibility and simplicity, allowing them to regain control over their calendar and healthcare.

Learn more in a recent issue of ONdrugDelivery Magazine about the potential benefits for patients and healthcare providers of innovative subcutaneous delivery and the flexibility of the enFuse: https://lnkd.in/g7WWHvUY

17/11/2022

This Expert View is from the recently released Sustainability issue of ONdrugDelivery: "THE ENVIRONMENTAL IMPACT OF GLOBAL SUPPLY CHAIN LOGISTICS & SUPPLIER SELECTION". Full article 👉https://bit.ly/3tCinPZ

Team Consulting's Alastair Willoughby looks at the factors affecting sustainability when considering global supply chain logistics and supplier selection.

09/11/2022

Just published and ready to read online - "Drug Delivery & Environmental Sustainability" - the Oct/Nov issue of ONdrugDelivery Magazine (Issue #139). Link to all the articles in full is here 👉 https://bit.ly/3WKyAjk

Focusing on sustainability from cover-to-cover, this issue represents a valuable guide to sustainability as it pertains specifically to the development process and manufacturing supply chain for drug delivery systems, including syringes and other injection devices, inhalers, nasal sprays, ocular delivery systems, and other dosage forms.

We're pleased to have, inside this edition, contributions from numerous true experts in this field. Their insightful articles include:

- detailed analyses of the impact of the healthcare industry, including delivery devices and primary packaging, on the environment (, Team Consulting, Phillips-Medisize)

- valuable guidelines and advice on how to implement sustainable device design, development and manufacturing (Kestrel Technology Consulting, Flex, PA Consulting)

- stories from device companies and CDMOs about how they have set and are meeting sustainability targets within their organisations, in order to ensure a sustainable offering as suppliers to their pharma/biopharma industry partners and customers (Aptar Pharma, Ypsomed, Recipharm).

Additional support for this issue comes from Celanese Corporation, DCA Design International Ltd, Jabil Healthcare and Qualicaps.

Link to all the content here 👉 https://bit.ly/3WKyAjk

We hope you enjoy this highly informative issue of ONdrugDelivery!

13/10/2022

In case you missed it! Ypsomed's article in October's ONdrugDelivery, "THE NEW YPSOMATE™ 5.5 – TAKING HANDHELD SELF-INJECTION BEYOND VOLUMES OF 2 ML". Full text 👉 https://bit.ly/3g8Lfvm

Reto Jost introduces YpsoMate 5.5, the staked-needle-syringe-based, two-step autoinjector for injection volumes in the 2.0–5.5 mL range, discusses the drivers of the demand for high-volume, high-rate subcutaneous drug delivery using handheld autoinjectors and explains the design rationale of this new injection device.

Read the full article 👉 https://bit.ly/3g8Lfvm

12/10/2022

It's here, ready for you to read now! "Prefilled Syringes & Injection Devices" - October's ONdrugDelivery (Issue #138). Link to all the articles in full is here 👉 https://bit.ly/3epbFst

With more content than any issue we've ever published, all 100% focused on the design, development, manufacture and supply of devices for parenteral drug delivery, this edition's main themes include:

- Innovative solutions for delivering large-volumes

-Reconstitution of lyophilised formulations / novel dual chamber devices

- Novel approaches and technologies for the industrialisation and manufacture of injection devices

- Importance of technology platforms

- Gas as a power source for injection devices

- Needle-free injection

- Connectivity / smart devices

- Sustainability

We're incredibly grateful for the excellent contributions and strong support for this issue from the industry, both from regular supporters Ypsomed 3P Innovation Ltd, Aptar Pharma Injectables, Biocorp, Cambridge Design Partnership, CCBio, Celanese Corporation, Congruence Medical Solutions, Credence MedSystems, DCA Design International, Gerresheimer, Haselmeier (Medmix), Medical Engineering Technologies, Nemera, Nipro PharmaPackaging, Owen Mumford Pharmaceutical Services, Phillips-Medisize, Steel Portal Instruments, SCHOTT Pharma, SHL Medical, Stevanato Group, Teamtechnik Maschinen und Anlagen, and West Pharmaceutical Services,; and we're pleased to welcome several companies to our pages for the first time also - Aktiv Pharma, Altaviz, Injecto a/s, KORU Medical Systems, Simatec and Windgap Medical.

Link to all the content here 👉 https://bit.ly/3epbFst

We hope you enjoy this superb issue of ONdrugDelivery Magazine!

11/10/2022

https://www.ondrugdelivery.com/magazines/

03/10/2022

From September's Wearable Injectors issue of ONdrugDelivery Magazine, "THE EVOLUTION OF WEARABLES – REPRESENTING THE VOICE OF THE ENTIRE ECOSYSTEM". Full article 👉
https://bit.ly/3dZBFuq

Lauren Orme, Victoria Morgan and Shari Krusniak consider the current landscape for on-body delivery systems and discuss how West Pharmaceutical Services, is responding to the demands of various stakeholders.

29/09/2022

From September's Wearable Injectors issue of ONdrugDelivery: "DRUG DELIVERY DEVICES THROUGHOUT THE DRUG DEVELOPMENT CYCLE". Read the full article 👉 https://bit.ly/3RjNBod

Ori Ben-David discusses the considerations that must be made over the course of injectable drug development and how Eitan Medical’s Sapphire™ and Sorrel™ platforms offer pharmaceutical companies a full suite of device tools from early discovery through to commercialisation.

28/09/2022

From September's Wearable Injectors issue of ONdrugDelivery, "A NEW MEMS ENGINE FOR LARGE-VOLUME SUBCUTANEOUS INJECTORS". Read the full article here: https://bit.ly/3SpUypk .

Jiunn-Ru Lai, Tsung-Chieh Cheng and Brian Li discuss how MicroMED’s Primary Actuator technology for driving high-volume, high-viscosity injection devices compares with current spring and motor technologies.

27/09/2022

From September's Wearable Injectors issue of ONdrugDelivery Magazine, "FLEXIBLE CARE – ENABLE WEARABLE DELIVERY". Read the article here: https://bit.ly/3LJgmK1.

Jennifer Estep and Mehul Desai of Enable Injections discuss the benefits for patients and healthcare providers of innovative subcutaneous delivery.